Adjuvant Sunitinib in Renal-Cell Carcinoma.

@article{Zhang2017AdjuvantSI,
  title={Adjuvant Sunitinib in Renal-Cell Carcinoma.},
  author={Sheng Zhang},
  journal={The New England journal of medicine},
  year={2017},
  volume={376 9},
  pages={893}
}
To the Editor: Ravaud et al. (Dec. 8 issue)1 describe a landmark trial of adjuvant therapy for renal-cell carcinoma. However, the goal of therapy in patients with cancer is to increase the length and quality of their lives, and this goal was not met in the trial. Although a significant increase in the duration of disease-free survival was achieved, it was not translated into an overall survival benefit. The overall and net benefit of adjuvant sunitinib is in some doubt. Patients might still… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-9 of 9 extracted citations

Similar Papers

Loading similar papers…